Understanding Antibiotics Misuse in Nigeria: A Detailed Study

By Staff Writer

October 17, 2023

Concerning Inappropriate Use of Antibiotics

In middle income countries such as Nigeria, the improper use of antibiotics poses a significant risk to the general population’s health. A recent investigation into consumers’ knowledge, perceptions, and the factors related with this usage was carried out in Ibadan, Nigeria. An alarmingly high percentage of consumers (95.9%) felt that antibiotics could prevent the growth of bacteria, and 60.7% believed that they could treat all infections using antibiotics. Unbelievably, 57.4% of respondents were not aware of antibiotic resistance, and just 14.7% of respondents possessed adequate information regarding antibiotics.

Factors That Influence the Improper Use of Antibiotics

The study revealed that 72.5% of customers have used antibiotics within the previous 12 months. Doctors prescribed antibiotics most often for Malaria, with amoxicillin being the most frequently used drug. Several factors significantly influenced the misuse of antibiotics. These included delayed test results, the belief that antibiotics offer instant relief, and the closeness of the pharmacy to a person’s home or workplace. 

Findings

This study reveals a crucial need for better public education about proper antibiotic use. Despite respondents having a high level of education, they still lack significant understanding of how to correctly use antibiotics and the risks of misuse. Social influences and antibiotic myths widen this knowledge gap. It’s not only false but also dangerous to believe that antibiotics can cure all diseases, stop diarrhea, or serve as a preventative measure after unprotected sex. These are all myths. Believing these misconceptions can lead to misuse or overuse of antibiotics. This behavior contributes to the global issue of antibiotic resistance.

This study revealed a concerning trend of consumers commonly self-medicating with antibiotics like amoxicillin, ampicillin, ciprofloxacin, tetracycline, and metronidazole. The low cost and easy over-the-counter availability of these antibiotics contribute to their overuse. We should avoid this practice because it increases the risk of antibiotic resistance. Another concern is the prescription of antibiotics for non-bacterial illnesses, such as uncomplicated malaria. Protozoa, not bacteria, cause malaria. While many antibiotics can treat malaria, their improper use could create resistant strains of the disease. 

Conclusion

The vast majority of customers lacked adequate understanding about the proper way to take antibiotics, which resulted in their inappropriate application of antibiotics. In order to increase understanding and encourage the correct application of antibiotics, specialised educational initiatives are required. There should be a stricter enforcement of the regulations that regulate the dispensing and marketing of antibiotics together with the provision of proper counseling.

Reference url

Recent Posts

preventive health costs
       

Prevention Valuation: Fund Health, Not Just Savings

💡 Is prevention really saving us money in healthcare?

In their thought-provoking article, “Can Prevention Save Money?”, Baicker and Chandra challenge the prevailing notion that preventive health measures always reduce costs. They argue that while prevention can enhance health outcomes, it often leads to increased spending upfront, and the key lies in evaluating these programs based on their cost-effectiveness instead of expecting them to save money outright.

Curious about the real financial implications of preventive care? Dive into the full analysis to uncover the nuances!

#SyenzaNews #HealthEconomics #costeffectiveness #healthcarepolicy

FDA AI Drug Approval
          

FDA AI Drug Approval

🚀 Are we on the brink of a new era in drug approval?

The FDA’s new AI initiative is set to reshape how we evaluate new therapies by dramatically speeding up the review process. With generative AI tools already cutting down review times from days to mere minutes, this breakthrough will not only enhance efficiency but also enable scientists to focus on more impactful work.

Curious about the implications for market access, patient outcomes, and health economics? Dive into the full article to explore how the future of pharmaceutical approvals is being transformed!

#SyenzaNews #regulatoryaffairs #AIinHealthcare #innovation

HCV treatment advancements
      

HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel

🌍 Are we on the brink of a new era in Hepatitis C treatment?

Atea Pharmaceuticals is hosting a virtual KOL panel on May 14, 2025, featuring top experts discussing the challenges faced by HCV patients and sharing insights from the promising results of their Phase 2 study on bemnifosbuvir and ruzasvir. This could be a game-changer in advancing HCV treatments through ongoing Phase 3 trials.

Don’t miss out on how these developments might reshape the future landscape for HCV patients! Click to read more about the panel and the innovative therapies in the pipeline.

#SyenzaNews #biotechnology #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.